featured
Sulindac and Erlotinib for Duodenal Neoplasia in Familial Adenomatous Polyposis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial
JAMA 2016 Mar 22;315(12)1266-1275, NJ Samadder, DW Neklason, KM Boucher, KR Byrne, P Kanth, W Samowitz, D Jones, SV Tavtigian, MW Done, T Berry, K Jasperson, L Pappas, L Smith, D Sample, R Davis, MK Topham, P Lynch, E Strait, W McKinnon, RW Burt, SK KuwadaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.